<< Back

Dr. Rothman is a physician and medical entrepreneur. In 1990, he founded a RI company called Clinical Studies Ltd. Clinical Studies Ltd. grew to become the largest wholly-owned clinical research company in the world consisting of fifty-three research centers performing clinical trials in Phase I, II, III, and IV in every major therapeutic category. Dr. Rothmann and his associates completed a successful sale of the company in 1996 for $100 million dollars. Subsequently, Dr. Rothmann built a twenty-three center domestic oncology research network, and a twenty center nursing home research company called Geriatric Science Institute. He has been the President, CEO, Chief Medical Officer, and Chairman of the Ethics Committee.

Dr Rothman is founder and a board member of Pharmastar, Inc. a company that runs international investigator meetings for the pharmaceutical industry, and specializes in rater training and inter-rater reliability. He is also co-founder of both Collegium Pharmaceutical of Cumberland RI, and of Neurologia Cognitiva Research, an international CNS research company.

Dr. Rothman is a graduate of the University of Michigan and Boston University Medical School, has served on the faculties of Dartmouth-Hitchcock Medical Center, Harvard University Medical School, and Massachusetts General Hospital and as Medical Director of the Princeton Center for Behavioral Consultation. He is a prolific inventor and has built several companies around his inventions. He is the winner of the Massachusetts Institute of Technology Innovation Center Award.

Dr. Rothman is the founder of End Teen Cruelty, a national non-profit company dedicated to dealing with the cruelty of children to other children, and of Charitable Benefactors, a company that helps develop for-profit companies that contribute a significant percentage of profits to non-profit causes.